Instrument Business Outlook Volume 32 - Issue 7

17 Jul 2023

Categories:

Instrument Business Outlook

Table of Contents

R&D as Percentage of Sales Stays Mostly Consistent in FY22
- Sales & R&D Growth
- R&D as a Percentage of Sales
- Conclusion
MS Survey Finds Some Labs Delaying Purchases
Executive Briefing
- EU Fines Illumina $475 Million
- Thermo Fisher Makes $900 Million Deal
- Abcam Announces Preliminary Results
- NanoString Provides Preliminary Results and Litigation Update
- Biosynth Buys CDMO
First Quarter Results: 10x Genomics, HORIBA, Oxford Instruments and Pacific Biosciences
- 10x Genomics Records Quarterly Growth Despite Challenges in China
- HORIBA Produces Mixed Sales Results for the First Quarter
- Oxford Instruments Ends Its Fiscal 2023 With Strength
  - Overview
  - Orders
  - Divisions
  - Regions
  - End-Markets
  - Guidance
- Pacific Biosciences Begins 2023 Strongly
Market Profile: Adsorbable Organic Halogen Analyzers (AOX)
- Leading Vendors
- Largest Markets
- Instrument Cost
Industry Watch
- Chemicals: Latest Forecast
- Biopharma: Drug Origins
- Food: Cell-Based Meat Gain US Approval
Region Watch
- EU: GMO Legislation Update
- Germany: Chemical Makers’ R&D Rises
- India: Major Research Agency Takes Shape
News
- Life Science Instruments
  - Product Introductions
  - Gene-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Cell-Based Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
  - Protein-Based Analysis
  - Company Announcements
  - Product Introductions
- Chromatography
  - Company Announcements
  - Product Introductions
- Materials Characterization
  - Company Announcements
  - Product Introductions
- Bioprocess Analysis
  - Company Announcements
  - Product Introductions
  - Sales & Orders of Note
- Process Analysis
  - Company Announcements
  - Product Introductions
Bottom Line

Attachments

IBO 071723 Issue.pdf